Moderna announces early-stage hantavirus vaccine research

11 articles · Updated · The Boston Globe · May 8

The Cambridge company said it is working with the US Army institute and Korea University, while WHO has identified six cases, two suspected cases and three deaths linked to the Hondius.
Moderna said the work began before the Dutch-flagged cruise ship outbreak and forms part of its effort to prepare countermeasures against emerging infectious diseases; its shares rose 12%.
Known for its Covid shot, Moderna is also running a late-stage bird flu vaccine trial, despite losing US health department funding last year for bird flu and other vaccine programmes.

Is Moderna's stock rally a hantavirus-fueled bubble, or does its cancer vaccine justify the massive surge?

As a rare human-to-human hantavirus spreads, are health officials too quick to dismiss the threat of another pandemic?